Drawing for RIVFLOZA

USPTO serial 90191150

RIVFLOZA

Reviewed by CopyMark Law Group

Reg. 7482490Status 700Registered
Filing date
Status date
Registration date
Aug 20, 2024
Examiner
GALBO, AMANDA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with RIVFLOZA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Spencer Beall

Spencer Beall White & Case LLP1221 Avenue of the AvenuesTrademark DepartmentNew York, NY 10020

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of various diseases, namely, pharmaceutical preparations for the treatment of rare diseases in the nature of genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; drug delivery agents in the nature of oligonucleotide compounds for use in the targeted delivery of RNAi therapy; chemical compounds that act as a platform for the delivery of drugs in the nature of drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticalsACTIVEMar 19, 2024
042Scientific research and development of pharmaceutical preparations, compounds for use in the targeted delivery of therapy, chemical compounds that act as a platform for the delivery of drugs, and drug delivery agents; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trialsACTIVEMar 19, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 20, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 20, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 16, 2024SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jul 16, 2024CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jun 13, 2024SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jun 12, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 8, 2024IUAFUSE AMENDMENT FILED—
May 8, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 4, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 3, 2024EX4GSOU EXTENSION 4 GRANTED—
May 3, 2024EXT4SOU EXTENSION 4 FILED—
May 3, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 21, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 19, 2023EX3GSOU EXTENSION 3 GRANTED—
Oct 19, 2023EXT3SOU EXTENSION 3 FILED—
Oct 19, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 12, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 12, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Oct 12, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 12, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 12, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 12, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 4, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
May 5, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 3, 2023EX2GSOU EXTENSION 2 GRANTED—
May 3, 2023EXT2SOU EXTENSION 2 FILED—
May 3, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 7, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 7, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 7, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 5, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 3, 2022EX1GSOU EXTENSION 1 GRANTED—
Nov 3, 2022EXT1SOU EXTENSION 1 FILED—
Nov 3, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 25, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 25, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 25, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 3, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 8, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 8, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 16, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 2, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 2, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 2, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 2, 2022ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Feb 2, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 2, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 2, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 13, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 13, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 13, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 5, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 5, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 5, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 5, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 5, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 2, 2021GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 2, 2021GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 2, 2021CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 31, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 30, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 30, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 25, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 25, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 25, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 3, 2021GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Feb 3, 2021GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Feb 3, 2021CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Feb 3, 2021DOCKASSIGNED TO EXAMINER—
Oct 27, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 22, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance